SEP 22, 2021 3:00 AM PDT

Whole Genome Sequencing for Cancer Diagnostics

WRITTEN BY: Katie Kokolus

The human genome consists of genetic material known as DNA.  We all have unique DNA sequences made up of four bases: adenine (A), cytosine (C), guanine (G), and thymine (T).  The pattern these bases make up in an individual creates a unique DNA fingerprint. 

The unique pattern created by ACGT forms the genetic code.  The ribosome, a complex molecule made up of various proteins, translates the genetic code and facilitates the generation of proteins. 

Bases attached to a sugar molecule and a phosphate group form a nucleotide, and every series of three nucleotides codes for an amino acid. Many amino acids together generate a protein.    

Uncovering the order of bases in the genome is called sequencing. More specifically, whole genome sequencing determines the entire sequence of an organism at one time. Initially used for research and development, this technology has evolved into a diagnostic tool.

With the advancement of numerous targeted therapies, the efficacy of which rely on the presence of specific genetic markers in the patient, there is a growing necessity for efficient techniques to understand an individual patient’s genetic makeup. 

Various tests measure the different markers needed to determine personalized cancer treatment regimens.  Therefore, a single method to screen for the growing number of cancer biomarkers would save precious time.  Making treatment decisions faster could save lives in populations with fast-growing tumors.  In addition, the amount of patient tissue available through biopsy samples is often limited, so maximizing the information garnered from a single assay is significant. 

A recent study published in The Journal of Molecular Diagnostics developed an optimized whole genome sequencing procedure which generated over a 95% success rate.  The single whole genome sequencing procedure detected numerous mutations and variants that otherwise require several different diagnostic panels and laboratory assays.  Importantly, this optimized diagnostic procedure takes ten or less days to complete.  

The authors indicate a significant limitation of the procedure is the requirement of biopsies with a high concentration of tumor cells (>20%).  In addition, most clinics would have to modify standard methods used for sample collection and processing.

The study concludes that whole genome sequencing of tumors will produce valuable data enhancing the ability of researchers to understand how current therapies work, promote the discovery of new cancer biomarkers, and facilitate the development of new targeted therapies.  Moreover, this technology can provide valuable insight into how to better adapt personalized treatment regimens. 

 

Sources: whole genome sequencingribosomenucleotidetargeted therapiesThe Journal of Molecular Diagnostics

About the Author
  • PhD in Tumor Immunology. I am interested in developing novel strategies to improve the efficacy of immunotherapies used to extend cancer survivorship.
You May Also Like
JUN 15, 2021
Cancer
Red seaweed consumption is associated with a low risk of colon cancer - but why?
JUN 15, 2021
Red seaweed consumption is associated with a low risk of colon cancer - but why?
New research published in Marine Drugs explains why diets high in red seaweed are associated with a low risk of col ...
JUN 21, 2021
Cancer
Analyzing breast implant topography and associated immune responses
JUN 21, 2021
Analyzing breast implant topography and associated immune responses
In an effort to understand how breast implants influence the immune system, researchers from MIT have led an analysis to ...
AUG 18, 2021
Technology
Tracking System Maps How Cancer Cells Evolve, Providing New Treatment Insights
AUG 18, 2021
Tracking System Maps How Cancer Cells Evolve, Providing New Treatment Insights
All cells in a tumor share some genetic similarities, but also have key differences, often hindering effective treatment ...
AUG 19, 2021
Cancer
Japanese Berry Vine Could Treat Lung Cancer
AUG 19, 2021
Japanese Berry Vine Could Treat Lung Cancer
A berry-producing vine in Japan has shown promise in mouse models for treating lung cancer. The corresponding study was ...
OCT 07, 2021
Cell & Molecular Biology
Color-Changing Slides Improve Accuracy in Cancer Diagnosis
OCT 07, 2021
Color-Changing Slides Improve Accuracy in Cancer Diagnosis
When cancer is diagnosed, a sample has to be taken from a patient, treated, and analyzed. Researchers have now modified ...
OCT 10, 2021
Cell & Molecular Biology
DNA Can Reveal Treatments for Lung Cancer in 'Never-Smoked' Patients
OCT 10, 2021
DNA Can Reveal Treatments for Lung Cancer in 'Never-Smoked' Patients
There is a well-known causal connection between smoking and lung cancer, and most research on lung cancer has been focus ...
Loading Comments...